Anna Palmer

1.3k total citations
15 papers, 262 citations indexed

About

Anna Palmer is a scholar working on Epidemiology, Hepatology and Modeling and Simulation. According to data from OpenAlex, Anna Palmer has authored 15 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 7 papers in Hepatology and 3 papers in Modeling and Simulation. Recurrent topics in Anna Palmer's work include Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Anna Palmer is often cited by papers focused on Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Anna Palmer collaborates with scholars based in Australia, United States and Denmark. Anna Palmer's co-authors include Nick Scott, Paul Dietze, Peter Higgs, Margaret Hellard, Alisa Pedrana, Mark Stoové, Marshall E. Cates, Joseph Doyle, Rachel Sacks‐Davis and Greg Gorman and has published in prestigious journals such as Scientific Reports, Addiction and The Medical Journal of Australia.

In The Last Decade

Anna Palmer

13 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Palmer Australia	10	158	93	62	41	40	15	262
M Lyons United Kingdom	9	221 1.4×	159 1.7×	49 0.8×	64 1.6×	12 0.3×	12	309
Tatiana Carvalho Reis Martins Brazil	8	85 0.5×	74 0.8×	22 0.4×	15 0.4×	4 0.1×	46	220
Saiedeh Haji‐Maghsoudi Iran	9	133 0.8×	10 0.1×	63 1.0×	74 1.8×	12 0.3×	27	258
Lucia Craxì Italy	8	39 0.2×	32 0.3×	11 0.2×	50 1.2×	27 0.7×	12	159
Sione Crawford Australia	9	211 1.3×	96 1.0×	99 1.6×	55 1.3×	5 0.1×	24	297
Abdulaziz Bako United States	8	62 0.4×	15 0.2×	28 0.5×	46 1.1×	5 0.1×	32	191
Sisay Shewasinad Yehualashet Ethiopia	5	75 0.5×	18 0.2×	7 0.1×	11 0.3×	34 0.8×	10	199
Jacqueline A. Richmond Australia	11	220 1.4×	207 2.2×	15 0.2×	48 1.2×	2 0.1×	30	316
Tomáš Zábranský Czechia	11	229 1.4×	49 0.5×	89 1.4×	44 1.1×		22	337
Peter Meylakhs Russia	10	133 0.8×	21 0.2×	54 0.9×	54 1.3×	2 0.1×	18	207

Countries citing papers authored by Anna Palmer

Since Specialization

Citations

This map shows the geographic impact of Anna Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Palmer more than expected).

Fields of papers citing papers by Anna Palmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Palmer. The network helps show where Anna Palmer may publish in the future.

Co-authorship network of co-authors of Anna Palmer

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Palmer. A scholar is included among the top collaborators of Anna Palmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Palmer. Anna Palmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Draper, Bridget, Anna Palmer, Hla Htay, et al.. (2023). Cost‐effectiveness of a decentralized, community‐based “one‐stop‐shop” hepatitis C testing and treatment program in Yangon, Myanmar. JGH Open. 7(11). 755–764.

Palmer, Anna, Dominic Delport, Sherrie L. Kelly, et al.. (2023). Frequent and unpredictable changes in COVID-19 policies and restrictions reduce the accuracy of model forecasts. Scientific Reports. 13(1). 1398–1398. 3 indexed citations

Delport, Dominic, et al.. (2022). Cost optimisation analysis of the expanded programme for immunisation: balancing equity and coverage in Pakistan. BMJ Global Health. 7(10). e009000–e009000. 2 indexed citations

Palmer, Anna, Mark Stoové, Rebecca Winter, et al.. (2021). A costing analysis of a state-wide, nurse-led hepatitis C treatment model in prison. International Journal of Drug Policy. 94. 103203–103203. 12 indexed citations

Palmer, Anna, Anna L. Wilkinson, Campbell Aitken, et al.. (2021). Estimating the number of new hepatitis C infections in Australia in 2015, prior to the scale‐up of direct‐acting antiviral treatment. Journal of Gastroenterology and Hepatology. 36(8). 2270–2274. 3 indexed citations

Palmer, Anna, Judy Gold, Imogen Elsum, et al.. (2021). A modelling analysis of financial incentives for hepatitis C testing and treatment uptake delivered through a community‐based testing campaign. Journal of Viral Hepatitis. 28(11). 1624–1634. 10 indexed citations

Scott, Nick, Anna Palmer, Dominic Delport, et al.. (2020). Modelling the impact of reducing control measures on the COVID-19 pandemic in a low transmission setting. The Medical Journal of Australia. 1. 2 indexed citations

Scott, Nick, Anna Palmer, Dominic Delport, et al.. (2020). Modelling the impact of relaxing COVID ‐19 control measures during a period of low viral transmission. The Medical Journal of Australia. 214(2). 79–83. 48 indexed citations

Palmer, Anna, Nick Scott, Paul Dietze, & Peter Higgs. (2020). Motivations for crystal methamphetamine-opioid co-injection/co-use amongst community-recruited people who inject drugs: a qualitative study. Harm Reduction Journal. 17(1). 14–14. 57 indexed citations

10.

Palmer, Anna, Peter Higgs, Nick Scott, et al.. (2020). Prevalence and correlates of simultaneous, multiple substance injection (co‐injection) among people who inject drugs in Melbourne, Australia. Addiction. 116(4). 876–888. 12 indexed citations

11.

Palmer, Anna, Amanda Wade, Bridget Draper, et al.. (2019). A cost-effectiveness analysis of primary versus hospital-based specialist care for direct acting antiviral hepatitis C treatment. International Journal of Drug Policy. 76. 102633–102633. 21 indexed citations

12.

Doyle, Joseph, Anna Palmer, Joost W. Vanhommerig, et al.. (2019). Staying hepatitis C negative: A systematic review and meta‐analysis of cure and reinfection in people who inject drugs. Liver International. 39(12). 2244–2260. 32 indexed citations

13.

Scott, Nick, Anna Palmer, Chris Morgan, et al.. (2018). Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study. The Lancet Global Health. 6(6). e659–e667. 26 indexed citations

14.

Palmer, Anna, Marshall E. Cates, & Greg Gorman. (2018). The Association Between Lithium in Drinking Water and Incidence of Suicide Across 15 Alabama Counties. Crisis. 40(2). 93–99. 16 indexed citations

15.

Douglass, Caitlin, Cassandra Wright, Anna Palmer, et al.. (2017). “Just not all ice users do that”: investigating perceptions and potential harms of Australia’s Ice Destroys Lives campaign in two studies. Harm Reduction Journal. 14(1). 45–45. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact